🇺🇸 Liposome Irinotecan in United States

Liposome Irinotecan (Liposome Irinotecan) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Liposome Irinotecan in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Liposome Irinotecan approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Liposome Irinotecan in United States?

China Medical University, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.